• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钌(II)多吡啶配合物的合成、DNA 结合和拓扑异构酶抑制活性。

Synthesis, DNA-binding and topoisomerase inhibitory activity of ruthenium(II) polypyridyl complexes.

机构信息

MOE Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Optoelectronic Materials and Technologies, School of Chemistry and Chemical Engineering, Sun Yat-Sen University, Guangzhou 510275, PR China.

出版信息

Eur J Med Chem. 2011 Apr;46(4):1056-65. doi: 10.1016/j.ejmech.2011.01.019. Epub 2011 Jan 21.

DOI:10.1016/j.ejmech.2011.01.019
PMID:21295892
Abstract

Two ruthenium(II) complexes Ru(bpy)(2)(bfipH) (1) and Ru(phen)(2)(bfipH) (2) have been synthesized and characterized. The DNA-binding behaviors of complexes were studied by using spectroscopic and viscosity measurements. Results suggested that the two complexes bind to DNA in an intercalative mode. Complexes 1 and 2 can efficiently photocleave pBR322 DNA in vitro under irradiation, singlet oxygen ((1)O(2)) was proved to contribute to the DNA photocleavage process. Topoisomerase inhibition and DNA strand passage assay confirmed that two Ru(II) complexes acted as efficient dual inhibitors of topoisomerases I and II. In MTT cytotoxicity studies, two Ru(II) complexes exhibited antitumor activity against BEL-7402, HeLa, MCF-7 tumor cells. The AO/EB staining assay indicated that Ru(II) complexes could induce the apoptosis of HeLa cells.

摘要

已经合成并表征了两种钌(II)配合物 Ru(bpy)(2)(bfipH)(1)和Ru(phen)(2)(bfipH)(2)。通过光谱和粘度测量研究了配合物的 DNA 结合行为。结果表明,两种配合物以嵌入模式与 DNA 结合。配合物 1 和 2 在光照下可有效地在体外光解 pBR322 DNA,证明单线态氧((1)O(2))有助于 DNA 光解过程。拓扑异构酶抑制和 DNA 链通过实验证实,两种 Ru(II) 配合物是拓扑异构酶 I 和 II 的有效双重抑制剂。在 MTT 细胞毒性研究中,两种 Ru(II) 配合物对 BEL-7402、HeLa、MCF-7 肿瘤细胞表现出抗肿瘤活性。AO/EB 染色实验表明,Ru(II) 配合物可诱导 HeLa 细胞凋亡。

相似文献

1
Synthesis, DNA-binding and topoisomerase inhibitory activity of ruthenium(II) polypyridyl complexes.钌(II)多吡啶配合物的合成、DNA 结合和拓扑异构酶抑制活性。
Eur J Med Chem. 2011 Apr;46(4):1056-65. doi: 10.1016/j.ejmech.2011.01.019. Epub 2011 Jan 21.
2
Synthesis of ruthenium(II) complexes and characterization of their cytotoxicity in vitro, apoptosis, DNA-binding and antioxidant activity.合成钌(II)配合物及其体外细胞毒性、细胞凋亡、DNA 结合和抗氧化活性的表征。
Eur J Med Chem. 2010 Jul;45(7):3087-95. doi: 10.1016/j.ejmech.2010.03.042. Epub 2010 Apr 3.
3
Dual topoisomerase I and II poisoning by chiral Ru(II) complexes containing 2-thiophenylimidazo[4,5-f][1,10]phenanthroline derivatives.手性 Ru(II) 配合物中 2-噻吩基咪唑并[4,5-f][1,10]菲咯啉衍生物对拓扑异构酶 I 和 II 的双重毒化作用。
J Inorg Biochem. 2014 Jan;130:15-27. doi: 10.1016/j.jinorgbio.2013.09.015. Epub 2013 Oct 7.
4
Synthesis, DNA-binding and photocleavage studies of ruthenium complexes [Ru(bpy)2(mitatp)]2+ and [Ru(bpy)2(nitatp)]2+.钌配合物[Ru(bpy)2(mitatp)]2+和[Ru(bpy)2(nitatp)]2+的合成、DNA结合及光切割研究
J Inorg Biochem. 2009 Jun;103(6):881-90. doi: 10.1016/j.jinorgbio.2009.03.005. Epub 2009 Mar 25.
5
DNA-binding, topoisomerases I and II inhibition and in vitro cytotoxicity of ruthenium(II) polypyridyl complexes: [Ru(dppz)2L](2+) (L=dppz-11-CO2Me and dppz).钌(II)多吡啶配合物的DNA结合、拓扑异构酶I和II抑制作用及体外细胞毒性:[Ru(dppz)2L](2+) (L = dppz - 11 - CO2Me和dppz)
Spectrochim Acta A Mol Biomol Spectrosc. 2015 Jan 25;135:101-9. doi: 10.1016/j.saa.2014.06.147. Epub 2014 Jul 8.
6
Synthesis, visible light photocleavage, antiproliferative and cellular uptake properties of ruthenium complex [Ru(phen)2(mitatp)]2+.[Ru(phen)2(mitatp)]2+的合成、可见光光解、抗增殖和细胞摄取性质的研究。
Eur J Med Chem. 2012 Sep;55:146-54. doi: 10.1016/j.ejmech.2012.07.014. Epub 2012 Jul 15.
7
DNA-binding, photocleavage, cytotoxicity in vitro, apoptosis and cell cycle arrest studies of symmetric ruthenium(II) complexes.对称钌(II)配合物的 DNA 结合、光解、体外细胞毒性、细胞凋亡和细胞周期阻滞研究。
Eur J Med Chem. 2013 May;63:603-10. doi: 10.1016/j.ejmech.2013.03.015. Epub 2013 Mar 15.
8
Synthesis, DNA-binding, photocleavage, cytotoxicity and antioxidant activity of ruthenium (II) polypyridyl complexes.钌(II)多吡啶配合物的合成、DNA 结合、光解、细胞毒性和抗氧化活性。
Eur J Med Chem. 2010 Feb;45(2):564-71. doi: 10.1016/j.ejmech.2009.10.043. Epub 2009 Nov 4.
9
Ruthenium(II) mixed-ligand complex containing 2-(4'-benzyloxy-phenyl)imidazo[4,5-f][1,10]phenanthroline: synthesis, DNA-binding and photocleavage studies.含2-(4'-苄氧基苯基)咪唑并[4,5-f][1,10]菲咯啉的钌(II)混合配体配合物:合成、DNA结合及光裂解研究
J Inorg Biochem. 2007 Apr;101(4):700-8. doi: 10.1016/j.jinorgbio.2006.12.016. Epub 2007 Jan 17.
10
DNA-binding and photocleavage properties of Ru(II) polypyridyl complexes with DNA and their toxicity studies on eukaryotic microorganisms.钌(II)多吡啶配合物与DNA的DNA结合和光切割特性及其对真核微生物的毒性研究。
Nucleosides Nucleotides Nucleic Acids. 2009 Oct;28(10):953-68. doi: 10.1080/15257770903307060.

引用本文的文献

1
Design, synthesis, anticancer activity and molecular docking of quinoline-based dihydrazone derivatives.喹啉基双腙衍生物的设计、合成、抗癌活性及分子对接
RSC Adv. 2025 Jan 2;15(1):231-243. doi: 10.1039/d4ra06954d.
2
Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy-An Overview.癌症治疗中的双靶点拓扑异构酶/G-四链体药物——综述
Biomedicines. 2022 Nov 15;10(11):2932. doi: 10.3390/biomedicines10112932.
3
Synthesis, characterization, DNA binding, topoisomerase inhibition, and apoptosis induction studies of a novel cobalt(III) complex with a thiosemicarbazone ligand.
新型钴(III)配合物的合成、表征、DNA 结合、拓扑异构酶抑制和凋亡诱导研究,该配合物的配体为硫代半卡巴腙。
J Inorg Biochem. 2020 Feb;203:110907. doi: 10.1016/j.jinorgbio.2019.110907. Epub 2019 Nov 2.
4
Applications of Ruthenium Complex in Tumor Diagnosis and Therapy.钌配合物在肿瘤诊断与治疗中的应用。
Front Pharmacol. 2018 Nov 19;9:1323. doi: 10.3389/fphar.2018.01323. eCollection 2018.
5
Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity.芳香性对多吡啶钌(II)配合物抗癌活性的影响:合成、结构、DNA/蛋白质结合、亲脂性及抗癌活性
J Biol Inorg Chem. 2017 Oct;22(7):1007-1028. doi: 10.1007/s00775-017-1479-7. Epub 2017 Jul 10.
6
The induction of autophagy against mitochondria-mediated apoptosis in lung cancer cells by a ruthenium (II) imidazole complex.钌(II)咪唑配合物诱导肺癌细胞自噬以对抗线粒体介导的凋亡
Oncotarget. 2016 Dec 6;7(49):80716-80734. doi: 10.18632/oncotarget.13032.
7
DNA Interaction, Photocleavage and Topoisomerase I Inhibition by Ru(II) Complex with a New Ligand Possessing Phenazine Unit.含吩嗪单元的新型配体钌(II)配合物与DNA的相互作用、光裂解及对拓扑异构酶I的抑制作用
J Fluoresc. 2015 Sep;25(5):1527-35. doi: 10.1007/s10895-015-1644-8. Epub 2015 Aug 19.
8
Cytoxicity and apoptotic mechanism of ruthenium(II) amino acid complexes in sarcoma-180 tumor cells.钌(II)氨基酸配合物对肉瘤-180肿瘤细胞的细胞毒性及凋亡机制
PLoS One. 2014 Oct 17;9(10):e105865. doi: 10.1371/journal.pone.0105865. eCollection 2014.
9
Mitochondria are the primary target in the induction of apoptosis by chiral ruthenium(II) polypyridyl complexes in cancer cells.线粒体是手性钌(II)多吡啶配合物诱导癌细胞凋亡的主要靶点。
J Biol Inorg Chem. 2014 Mar;19(3):335-48. doi: 10.1007/s00775-013-1069-2. Epub 2013 Nov 28.
10
Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II.手性钌(II)蒽醌配合物作为拓扑异构酶 I 和 II 的双重抑制剂。
J Biol Inorg Chem. 2012 Jan;17(1):81-96. doi: 10.1007/s00775-011-0831-6. Epub 2011 Aug 21.